JPRN-jRCT2080222706未知1 期
A Single-center, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Assess the Safety and Pharmacokinetics of OPA-15406 Ointment in Healthy Adult Male Subjects (Phase 1 Trial)
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 40age old（—）
- 性别
- Male
入选标准
- •BMI {Body weight (kg) / [Height (m)]2}: at least 18.5 and less than 25.0
- •-Judged by the investigator or subinvestigator to be healthy based on test results at screening and prior to administration on Day 1 of the treatment period
排除标准
- •-Findings (sunburn, abrasions, tattoos, etc) on the back that affect the evaluation of the safety of the skin.
- •-Judged by the investigator or subinvestigator as inappropriate to participate in this trial for any other reasons.
研究者
相似试验
进行中（未招募）
不适用
A randomised, placebo-controlled, single-centre, double-blind study to evaluate the efficacy, safety and tolerability of topically applied piroxicam gel in patients with recurrent herpes labialisEUCTR2013-003239-31-DEHOV GmbH
已完成
不适用
A placebo-controlled, randomized, single-centre, two-way crossover study to assess choline levels in plasma after a single dose of Superba Boost or choline bitartrate in healthy volunteersHealthy volunteersDRKS00015828Aker BioMarine Antarctic AS18
尚未招募
不适用
A single-center, randomized, placebo-controlled, two-way crossover study to investigate the drug-drug interaction on the pharmacokinetics and pharmacodynamics of ACT-078573 and single-dose desipramine in healthy male subjectsinsomiasleeplessness10040998NL-OMON32097Actelion Pharmaceuticals20
进行中（未招募）
1 期
Renohemodynamic Effects empaGliflozin in vaRiOUs PopulationsDiabetes Mellitus type 2EUCTR2020-000165-16-NLAmsterdam University Medical Center - location VU Medical Center72
撤回
4 期
A single-center, prospective, placebo-controlled, double-blind, randomized, cross-over mechanistic intervention study to investigate the effect of empagliflozin on kidney function in people with either preserved or impaired kidney function with or without type 2 diabetesType 2 Diabetes MellitusNL-OMON49123Vrije Universiteit Medisch Centrum72